Page 3 of 4
JournalꢀNameꢀ
Chemical Science
DOI: 10.1039/C4SC01768D
compound 2 esterified, on average, three of the eleven carboxylates This work was supported by grant R01 GM044783 (NIH). N.A.M.
(Fig. S1†). Using trypsin digestion coupled with mass spectrometry, was supported by postdoctoral fellowship F32 GM096712 (NIH).
we were able to identify the esterified residues. Diazo compound 2 K.A.A. was supported by a PhRMA predoctoral fellowship and by
(10 equiv) labelled Asp14, Glu49, Glu111, and Asp121, almost Molecular and Cellular Pharmacology Training Grant T32
exclusively. Diazo compound 1 (200 equiv) labelled a similar subset GM008688 (NIH). A.K.F.D. was supported by
a Hilldale
of residues (Glu9, Asp14, Glu49, Glu111, and the C terminus). The Undergraduate/Faculty Research Fellowship. J.E.L. was supported
basis for reaction with these particular residues is not clear, but by an NSF Graduate Research Fellowship. This work made use of
likely integrates the reactivity (i.e., high pKa) and accessibility of the National Magnetic Resonance Facility at Madison, which is
their carboxyl groups.
supported by grant P41 GM103399 (NIH), and the Biophysics
Most importantly, we probed the bioreversibility of our protein Instrumentation Facility, which was established with grants BIR-
esterification reaction (Fig. 2B). To enhance the relevance of this 9512577 (NSF) and S10 RR013790 (NIH).
experiment, we sought to employ esterases endogenous to human
Notes and references
cells rather than commercial enzymes. Accordingly, we used
recombinant DNA technology to add an 8-residue FLAG tag to the
N-terminus of RNase A, and we esterified the ensuing FLAG–
aDepartment of Chemistry, University of Wisconsin–Madison, 1101
University Avenue, Madison, WI 53706 USA. Email: rtraines@wisc.edu
RNase A with diazo compound 2 as described above. We found
bMolecular
& Cellular Pharmacology Graduate Training Program,
labelling to be comparable to that of wild-type RNase A (Fig. S12†),
and we observed that the enzyme lost half of its catalytic activity
upon esterification (Fig. S13†).41 Then, we incubated the esterified
protein with a HeLa cell extract. We recovered the enzyme from this
complex mixture with an anti-FLAG antibody immobilized on
magnetic beads. We could not detect any esters in the extract-treated
enzyme with mass spectrometry (Fig. S12†),42 and we found that the
enzyme had recovered all of its catalytic activity (Fig. S13†). These
data indicate that the protein esterification reaction was fully
bioreversible.
University of Wisconsin–Madison, 1300 University Avenue, Madison, WI
53706 USA
cDepartment of Biochemistry, University of Wisconsin–Madison, 433
Babcock Drive, Madison, WI 53706 USA
dGraduate Program in Cellular and Molecular Biology, University of
Wisconsin–Madison, 1525 Linden Drive, Madison, WI 53706 USA.
† Electronic Supplementary Information (ESI) available: Experimental
procedures, analytical data, and spectral data for novel compounds. See
DOI: 10.1039/b000000x/
‡ These authors contributed equally to this work.
Finally, we sought to demonstrate the generality of our
esterification method by employing a second protein substrate with a
different tag for its purification. Specifically, we applied diazo
compound 2 (10 equiv) and the conditions described above to the
mCherry variant of red fluorescent protein (RFP) from Discosoma sp.
We found that His6–RFP became esterified with 1–3 fluorenyl
groups. The protein did not lose its fluorescence during the
esterification reaction. As with RNase A, the esterification of RFP
was bioreversible. Incubation with a HeLa cell extract followed by
recovery with a Ni-affinity resin, yielded unmodified His6–RFP (Fig.
S13†). Success with both FLAG-labeled RNase A and His6-labeled
RFP indicates that our esterification method has a broad scope.
§ Present address for Prof. N. A. McGrath: Department of Chemistry,
University of Wisconsin–La Crosse, 1725 State Street, La Crosse, WI
54601 USA.
|| Present address for Dr. Jo E. Lomax: Science Exchange, 555 Bryant
Street, #939, Palo Alto, CA 94301 USA.
1
2
3
L. Tian, Y. Yang, L. M. Wysocki, A. C. Arnold, A. Hu, B.
Ravichandran, S. M. Sternson, L. L. Looger and L. D. Lavis, P. Natl.
Acad. Sci. USA, 2012, 109, 4756-4761.
B. Testa and J. M. Mayer, Hydrolysis in Drug and Prodrug
Metabolism: Chemistry, Biochemistry, and Enzymology, Academic
Press, New York, NY, 2003.
V. J. Stella, R. T. Borchardt, M. J. Hageman, R. Oliyai, M. Maag and J.
W. Tilley, eds., Prodrugs: Challenges and Rewards, Springer, New
York, NY, 2007.
Concluding remarks
4
5
L. D. Lavis, ACS Chem. Biol., 2008, 3, 203-206.
K. M. Huttunen, H. Raunio and J. Rautio, Pharmacol. Rev., 2011, 63,
750-771.
We find that a diazo compound can effect the efficient O-alkylation
of carboxylic acids in an aqueous environment near neutral pH, and
that this reactivity extends to proteins. The esters in the ensuing
protein can be hydrolysed by esterases that are endogenous to human
cells, thereby recreating the wild-type protein and avoiding a
compromise to function or the display of an epitope. By enabling the
facile semisynthesis of “proproteins” containing transitory
pharmacokinetic enhancing, cell-targeting, or cell-penetration
moieties, we envision that O-alkylation of carboxylic acids by diazo
compounds could broaden the utility of antibodies, enzymes,
hormones, and other proteins in chemical biology and
pharmacology.
6
7
8
9
S. Mukherjee, G. Keitany, Y. Li, Y. Wang, H. L. Ball, E. J. Goldsmith
and K. Orth, Science, 2006, 312, 1211-1214.
S. Mukherjee, Y.-H. Hao and K. Orth, Trends Biochem. Sci., 2007, 32,
210-216.
M. Aslam and A. Dent, eds., Bioconjugation, Macmillan Reference,
London, UK, 1998.
R. L. Lundblad, Chemical Reagents for Protein Modification, 3rd ed.,
CRC Press, Boca Raton, FL, 2005.
10 G. T. Hermanson, Bioconjugate Techniques, 2nd ed., Academic Press,
New York, NY, 2008.
11 M. Regitz and G. Maas, Diazo Compounds: Properties and Synthesis,
Academic Press, New York, NY, 1986.
12 A. Padwa and D. J. Austin, Angew. Chem. Int. Ed., 1994, 33, 1797-
1815.
13 Y. Zhang and J. B. Wang, Eur. J. Org. Chem., 2011, 1015-1026.
14 A. C. Chibnall, J. L. Mangan and M. W. Rees, Biochem. J., 1958, 68,
114-118.
Acknowledgements
15 M. P. Doyle, Chem. Rev., 1986, 86, 919-939.
Thisꢀjournalꢀisꢀ©ꢀTheꢀRoyalꢀSocietyꢀofꢀChemistryꢀ2012
ꢀ
J.ꢀName
.,ꢀ2012,ꢀ
00
,ꢀ1ꢁ3ꢀ|ꢀ
3
ꢀ